Conference Coverage
Conference Coverage
Single-fraction radiation therapy showed promise in metastatic Merkel cell carcinoma
Major finding: Complete response was seen in 52% of tumors in high-risk patients and 81% of tumors in low-risk patients (P = .008).
Conference Coverage
AUDIO: Challenges, rewards face creators of pediatric oncofertility clinics
Conference Coverage
Topical lidocaine reduces menopausal dyspareunia
Key clinical point: Consider lidocaine as an option for women with severe menopausal dyspareunia for whom estrogen therapy is not recommended....
News
E&M codes could soon require more rigor
Conference Coverage
Leukemic breast tumors may cause resistance in AML, ALL
Isabel Cunningham, MD, of Columbia University in New York, has found evidence to suggest that treatment resistance in leukemia patients may...
Conference Coverage
Team identifies potential treatment for FLT3-ITD AML
Credit: Eric Smith Researchers have presented evidence to support the use of a BET protein antagonist in FLT3-ITD-mutated acute myeloid leukemia...
Conference Coverage
Molecule shows preclinical activity in leukemias, lymphomas
SAN DIEGO—A small molecule that has previously proven effective against solid tumors exhibits activity against leukemias and lymphomas,...
Conference Coverage
Compound targets mutated DLBCL, WM cells
SAN DIEGO—A Toll-like receptor (TLR) antagonist can target B-cell lymphoma cells harboring the MYD88 L265P mutation, preclinical research suggests...
Conference Coverage
Reovirus shows synergy with agents used to treat MM
Six of the 7 MM cell lines tested were at least moderately sensitive to reovirus, and introducing the virus in combination with the proteasome...
Conference Coverage
Group describes mechanism of resistance in CLL
The study suggests the TNF-family member BAFF contributes to CLL cells’ resistance to direct and rituximab-induced natural killer (NK) cell...
Conference Coverage
Dual kinase inhibitor targets heterogeneity in AML
The inhibitor, SEL24-B489, targets both PIM and FLT3 mutants.